Artemis Medicare Services quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	311	275	+13.2%
EBITDA	54.8	50.6	+8.3%
EBITDA margin	17.6%	18.4%	−0.8 pts
Profit before tax	41.0	39.4	+4.1%
Net profit	31.1	30.0	+3.7%
EPS	₹1.96	₹1.90	+3.2%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	311	287	279	272	275	255	240	232	241	223	225	219	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	8.1	5.4	7.8	7.5	7.7	6.9	12.3	8.8	7.4	4.4	1.9	1.8
	319	293	287	280	282	262	252	241	249	228	227	221
	63.5	60.0	60.4	64.1	64.6	64.7	58.5	55.8	58.6	79.4	54.7	53.9
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	44.1	42.8	45.0	43.4	39.3	38.4	39.1	37.5	35.9	35.9	36.1	34.7
	7.4	6.5	6.4	6.7	7.2	7.4	7.8	8.0	8.0	8.1	8.6	8.0
	14.5	12.7	12.8	12.4	11.7	11.2	11.7	11.5	11.2	10.8	11.0	10.2
	149	128	122	120	120	110	106	102	105	71.8	96.6	97.6
	278	250	247	247	243	232	224	214	218	206	207	204
	54.8	56.4	51.6	44.6	50.6	41.4	35.9	37.5	42.3	36.2	38.0	32.6
	40.3	43.7	38.8	32.1	38.9	30.2	24.2	26.0	31.1	25.4	26.9	22.5
Profit
	41.0	42.6	40.3	32.8	39.4	29.8	28.7	26.8	30.6	21.6	20.2	16.3
	0.0	0.0	0.0	−3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	41.0	42.6	40.3	29.8	39.4	29.8	28.7	26.8	30.6	21.6	20.2	16.3
	8.7	10.0	7.6	6.5	8.2	6.7	3.8	5.9	7.0	4.6	4.3	2.1
	1.2	1.1	2.4	1.1	1.2	1.9	2.0	0.3	1.4	0.5	1.6	2.6
	9.9	11.2	10.0	7.5	9.4	8.6	5.7	6.2	8.4	5.1	5.9	4.8
	31.1	31.4	30.3	22.2	30.0	21.2	22.9	20.6	22.1	16.5	14.3	11.6
	31.1	31.4	30.3	22.2	30.0	21.2	22.9	20.6	22.1	16.5	14.3	11.6
	−0.4	−0.0	0.3	−0.3	−0.1	−0.0	0.5	−0.2	−0.3	−0.1	0.1	−0.0
	30.7	31.4	30.6	21.9	29.9	21.2	23.4	20.4	21.8	16.5	14.4	11.5
	31.0	31.3	30.0	22.3	30.0	21.3	23.0	20.7	22.3	16.7	14.2	11.5
	0.1	0.1	0.2	−0.1	0.0	−0.1	−0.1	−0.1	−0.1	−0.1	0.1	0.0
Per share
	₹1.96	₹1.98	₹1.90	₹1.41	₹1.90	₹1.35	₹1.47	₹1.32	₹1.42	₹1.14	₹1.04	₹0.85
	₹1.96	₹1.98	₹1.90	₹1.41	₹1.89	₹1.35	₹1.45	₹1.31	₹1.41	₹1.12	₹1.02	₹0.83
Other comprehensive income — detail
	−0.4	−0.0	0.3	−0.3	−0.1	−0.0	0.5	—	—	—	—	—
	−0.6	−0.1	0.4	−0.5	−0.2	−0.1	0.6	−0.3	−0.5	−0.1	0.1	−0.0
	−0.2	−0.1	0.1	−0.2	−0.1	−0.1	0.1	—	—	—	—	—
	—	—	—	—	—	—	—	−0.1	−0.2	−0.1	−0.0	0.0
	30.6	31.3	30.3	22.0	29.9	21.2	23.5	20.5	21.9	16.6	14.3	11.5
	0.1	0.1	0.2	−0.1	0.0	−0.1	−0.1	−0.1	−0.1	−0.1	0.1	0.0
Per share — as-filed variants
	₹1.96	₹1.98	₹1.90	₹1.41	₹1.90	₹1.35	₹1.47	₹1.32	₹1.42	₹1.14	₹1.04	₹0.85
	₹1.96	₹1.98	₹1.90	₹1.41	₹1.89	₹1.35	₹1.45	₹1.31	₹1.41	₹1.12	₹1.02	₹0.83
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	248	227	219	208	210	190	181	177	183	144	171	165
	79.6%	79.1%	78.4%	76.5%	76.5%	74.6%	75.6%	76.0%	75.7%	64.4%	75.7%	75.4%
Adjusted (ex-exceptional items) — derived
	41.0	42.6	40.3	32.8	39.4	29.8	28.7	26.8	30.6	21.6	20.2	16.3
	0.0	0.0	0.0	−3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	31.1	31.4	30.3	24.5	30.0	21.2	22.9	20.6	22.1	16.5	14.3	11.6
	₹1.96	₹1.98	₹1.90	₹1.56	₹1.90	₹1.35	₹1.47	₹1.32	₹1.42	₹1.14	₹1.04	₹0.85

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ARTEMISMED₹297.95

Artemis Medicare Services Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersINDRAMEDCO SHALBY GKSL GPTHEALTH LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹4,717 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	218.8	225.2	223.2	241.4	232.4	239.9	255.0	274.7	272.4	279.2	287.3	311.0
Other Income	1.8	1.9	4.4	7.4	8.8	12.3	6.9	7.7	7.5	7.8	5.4	8.1
Total Income	220.6	227.1	227.6	248.9	241.2	252.2	261.9	282.4	279.8	287.0	292.7	319.1
Expenses
+ Cost of Materials Consumed	53.9	54.7	79.4	58.6	55.8	58.5	64.7	64.6	64.1	60.4	60.0	63.5
+ Changes in Inventories	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
+ Employee Benefit Expense	34.7	36.1	35.9	35.9	37.5	39.1	38.4	39.3	43.4	45.0	42.8	44.1
+ Finance Costs	8.0	8.6	8.1	8.0	8.0	7.8	7.4	7.2	6.7	6.4	6.5	7.4
+ Depreciation & Amortisation	10.2	11.0	10.8	11.2	11.5	11.7	11.2	11.7	12.4	12.8	12.7	14.5
+ Other Expenses	97.6	96.6	71.8	104.7	101.7	106.4	110.4	120.2	120.3	122.2	128.1	148.6
Total Expenses	204.3	206.9	206.0	218.3	214.4	223.6	232.1	243.0	247.0	246.8	250.1	278.1
EBITDA	32.6	38.0	36.2	42.3	37.5	35.9	41.4	50.6	44.6	51.6	56.4	54.8
EBIT	22.5	26.9	25.4	31.1	26.0	24.2	30.2	38.9	32.1	38.8	43.7	40.3
Profit
PBT before Exceptional Items	16.3	20.2	21.6	30.6	26.8	28.7	29.8	39.4	32.8	40.3	42.6	41.0
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3.1	0.0	0.0	0.0
Pretax Income	16.3	20.2	21.6	30.6	26.8	28.7	29.8	39.4	29.8	40.3	42.6	41.0
+ Current Tax	2.1	4.3	4.6	7.0	5.9	3.8	6.7	8.2	6.5	7.6	10.0	8.7
+ Deferred Tax	2.6	1.6	0.5	1.4	0.3	2.0	1.9	1.2	1.1	2.4	1.1	1.2
Tax Expense	4.8	5.9	5.1	8.4	6.2	5.7	8.6	9.4	7.5	10.0	11.2	9.9
Net Income	11.6	14.3	16.5	22.1	20.6	22.9	21.2	30.0	22.2	30.3	31.4	31.1
+ Net Income — Continuing Ops	11.6	14.3	16.5	22.1	20.6	22.9	21.2	30.0	22.2	30.3	31.4	31.1
+ Other Comprehensive Income	-0.0	0.1	-0.1	-0.3	-0.2	0.5	-0.0	-0.1	-0.3	0.3	-0.0	-0.4
Total Comprehensive Income	11.5	14.4	16.5	21.8	20.4	23.4	21.2	29.9	21.9	30.6	31.4	30.7
Net Income to Common	11.5	14.2	16.7	22.3	20.7	23.0	21.3	30.0	22.3	30.0	31.3	31.0
Minority Interest	0.0	0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0.0	-0.1	0.2	0.1	0.1
Per Share
Basic EPS	0.85	1.04	1.14	1.42	1.32	1.47	1.35	1.90	1.41	1.90	1.98	1.96
Diluted EPS	0.83	1.02	1.12	1.41	1.31	1.45	1.35	1.89	1.41	1.90	1.98	1.96
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	0.5	-0.0	-0.1	-0.3	0.3	-0.0	-0.4
+ Items NOT to be Reclassified to P&L	-0.0	0.1	-0.1	-0.5	-0.3	0.6	-0.1	-0.2	-0.5	0.4	-0.1	-0.6
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	0.1	-0.1	-0.1	-0.2	0.1	-0.1	-0.2
+ Tax on Items NOT to be Reclassified — alt tag	0.0	-0.0	-0.1	-0.2	-0.1	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	11.5	14.3	16.6	21.9	20.5	23.5	21.2	29.9	22.0	30.3	31.3	30.6
Comprehensive Income — Non-controlling Interests	0.0	0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0.0	-0.1	0.2	0.1	0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.85	1.04	1.14	1.42	1.32	1.47	1.35	1.90	1.41	1.90	1.98	1.96
Diluted EPS — Continuing Operations	0.83	1.02	1.12	1.41	1.31	1.45	1.35	1.89	1.41	1.90	1.98	1.96
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	164.9	170.6	143.8	182.8	176.6	181.4	190.2	210.1	208.2	218.8	227.3	247.5
Gross Margin %	75.38	75.74	64.44	75.74	76.00	75.61	74.62	76.48	76.46	78.36	79.12	79.58
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	16.3	20.2	21.6	30.6	26.8	28.7	29.8	39.4	32.8	40.3	42.6	41.0
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3.1	0.0	0.0	0.0
Net Income Adj (tax-effected)	11.6	14.3	16.5	22.1	20.6	22.9	21.2	30.0	24.5	30.3	31.4	31.1
EPS Adj	0.85	1.04	1.14	1.42	1.32	1.47	1.35	1.90	1.56	1.90	1.98	1.96
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	13.6	13.6	13.7	13.8	13.8	13.8	13.9	13.9	15.8	15.8	15.8	15.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Artemis Medicare Services Q2 FY27 results (July–September 2026)

Filed with NSE on Friday, 30 October 2026 at 5:45 pm IST

Artemis Medicare Services (NSE: ARTEMISMED) reported its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026 at 5:45 pm IST. Consolidated net profit was ₹31 crore, up 3.5% from ₹30 crore in Q2 FY26 and down 0.9% from ₹31.3 crore in Q1 FY27. Revenue from operations was ₹311 crore, up 13.2% year on year and up 8.3% from the previous quarter.

Q2 FY26 results (a year earlier): 11 November 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹31 Cr+3.5% vs Q2 FY26−0.9% vs Q1 FY27
Revenue from operations: ₹311 Cr+13.2% vs Q2 FY26+8.3% vs Q1 FY27
Operating margin (EBIT): 13.0%−1.2 pts vs Q2 FY26−2.3 pts vs Q1 FY27EBIT ₹40.3 Cr
EBITDA: ₹54.8 Cr+8.3% vs Q2 FY26−2.9% vs Q1 FY27margin 17.6%
Earnings per share (basic): ₹1.96+3.2% vs Q2 FY26−1.0% vs Q1 FY27
Net profit margin: 10.0%−0.9 pts vs Q2 FY26−0.9 pts vs Q1 FY27

Questions

What was Artemis Medicare Services' net profit in Q2 FY27?

Consolidated net profit was ₹31 crore, up 3.5% from ₹30 crore in Q2 FY26 and down 0.9% from ₹31.3 crore in Q1 FY27.

What was Artemis Medicare Services' revenue in Q2 FY27?

Revenue from operations was ₹311 crore, up 13.2% year on year and up 8.3% from the previous quarter.

What was Artemis Medicare Services' EPS in Q2 FY27?

Basic earnings per share were ₹1.96, against ₹1.90 in Q2 FY26.

How were Artemis Medicare Services' Q2 FY27 results?

Both grew from a year earlier: net profit was up 3.5% at ₹31 crore and revenue was up 13.2% at ₹311 crore. The operating margin was 13.0%, down 1.2 percentage points from 14.2% a year earlier. Against Q1 FY27, net profit was down 0.9% and revenue up 8.3%.

What was Artemis Medicare Services' operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹40.3 crore, a margin of 13.0%, against 15.2% in Q1 FY27 and 14.2% in Q2 FY26. EBITDA was ₹54.8 crore, 17.6% of revenue.

What was Artemis Medicare Services' net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹62.3 crore, up 21.6% from ₹51.2 crore in the same months a year earlier. Revenue from operations was ₹598 crore, up 13.0%.

What is Artemis Medicare Services' net profit margin?

Artemis Medicare Services' net profit margin was 10.0% in Q2 FY27 (net profit as a share of revenue from operations), against 10.9% in Q2 FY26 (down 0.9 percentage points). For FY26 as a whole it was 9.6%.

What was Artemis Medicare Services' net profit in FY26?

Consolidated net profit was ₹104 crore in FY26 (April 2025–March 2026), up 25.4% from ₹82.6 crore in FY25. It was ₹49.1 crore in FY24 and ₹35.9 crore in FY23: up 188.7% over three years, 42.4% a year on average.

What was Artemis Medicare Services' revenue in FY26?

Revenue from operations was ₹1,081 crore in FY26 (April 2025–March 2026), up 15.4% from ₹937 crore in FY25. It was ₹879 crore in FY24 and ₹737 crore in FY23: up 46.6% over three years, 13.6% a year on average.

How has Artemis Medicare Services' profit changed over the last four quarters?

Net profit by quarter: ₹22.3 crore in Q3 FY26, ₹30 crore in Q4 FY26, ₹31.3 crore in Q1 FY27 and ₹31 crore in Q2 FY27. That is ₹115 crore over the four quarters, up 20.8% from ₹94.9 crore in the four quarters before. Revenue from operations: ₹272 crore, ₹279 crore, ₹287 crore and ₹311 crore.

When did Artemis Medicare Services announce its Q2 FY27 results?

On Friday, 30 October 2026 at 5:45 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 11 November 2025.

When will Artemis Medicare Services announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Artemis Medicare Services figures come from?

From Artemis Medicare Services' own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 30 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.